Frailty in hospitalised heart failure patients and the effects of heart failure specific pharmacotherapy in frail heart failure patients

Prevalence of frailty in hospialised patients and the effects of heart failure specific pharamacotherapy in frail heart failure patients: an observational study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ANZCTR

Registry ID

ACTRN12622000013763

Enrollment

2126

Registered

2022-01-11

Start date

2013-01-01

Completion date

2020-12-31

Last updated

2022-01-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Almost half of patients with heart failure may be frail and previous studies suggest that frail heart failure patients are less likely to receive evidence-based heart failure specific treatment. The prevalence of frailty among heart failure patients who needs hospitalisation in Australia is unknown. This study aims to determine the prevalence of frailty in heart failure patients and will also determine whether clinical outcomes among patients who received heart failure medications were different when compared to those who did not receive treatment.

Interventions

- This study involves determination of frailty status of hospitalised heart failure patients by use of the Hospital Frailty Risk Score (HFRS) - This study will include all data collected for all heart failure patients admitted between 2013-2020 from the electronic medical records

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

All patients 18 years or over who were admitted with a diagnosis of heart failure and admitted between 1 January 2013 to 31 December 2020 at Flinders Medical Centre (FMC) and Royal Adelaide Hospital (RAH), Adelaide, South Australia

Exclusion criteria

None

Outcome results